Pharmaceuticals
Perrigo Co rejects Mylan's $33-bn sweetened bid
25 Apr 2015
Generic drugmaker Mylan NV yesterday raised its takeover offer for Perrigo Co to $33 billion, in a move widely seen as an attempt to ward off an unsolicited bid from larger rival Teva Pharmaceuticals
Perrigo rejects Mylan’s $29 bn takeover offer
22 Apr 2015
Teva Pharmaceutical offers to buy Mylan NV for $40 bn
22 Apr 2015
A successful Teva-Mylan merger would be the largest in the pharmaceutical industry this year, which has seen acquisitions taking place at a frenzied pace
Daiichi Sankyo sells entire 9% stake in Sun Pharma for Rs20,420 cr
21 Apr 2015
Daiichi Sankyo said it would make an announcement concerning gains or losses on the sale of Sun Pharma shares when results of operations for the fiscal year ending in March 2015 are announced
Generic drug maker Mylan bids for Perrigo Co for $29 bn
09 Apr 2015
Founded in 1887, Perrigo is the world's largest manufacturer of over-the-counter drugs, nearly half of Perrigo’s $4.06-billion sales last year were generated from its consumer health-care division
Teva Pharmaceutical to buy US neurology drug firm Auspex $3.5 bn
31 Mar 2015
Auspex is a biopharmaceutical company specialising in applying deuterium chemistry to known molecules to create novel therapies with improved safety and efficacy profiles
Sun, Ranbaxy complete $4-bn merger
24 Mar 2015
On Tuesday, the Reserve Bank of India approved the issue of equity shares of Sun Pharma to non-resident holders of equity shares of Ranbaxy, facilitating the merger through a scheme of arrangement
CCI okays Shashun Pharma-Strides Arcolab merger
24 Mar 2015
HC blocks Glenmark from selling US firm’s diabetes drug
20 Mar 2015
A bench of Justices S Ravindra Bhat and Najmi Waziri, while granting the interim injunction, said Merck Sharp and Dohme "has established a prima facie case of patent infringement" by Glenmark
MSF flays Gilead’s hepatitis C ‘anti-diversion’ programme
19 Mar 2015
Campaigners have urged Indian generic manufacturers to reject Gilead Sciences’ highly-controversial programme to stop diversion of the drug to western markets, in a move that could compromise people’s treatment and confidentiality
Featured articles
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation
.jpg "CBDT explains Budget proposal on capital gains tax")
.jpg "Economic Survey projects India’s GDP growth at 6.5–7% in 2024-25")
.jpg "Adani-Sirus joint venture to acquire 77.5% stake in Coredge.io parent Parserlabs")
